Sales rise 9.41% to Rs 6305.70 crore
Net profit of Dr Reddy's Laboratories rose 11.89% to Rs 1114.20 crore in the quarter ended September 2022 as against Rs 995.80 crore during the previous quarter ended September 2021. Sales rose 9.41% to Rs 6305.70 crore in the quarter ended September 2022 as against Rs 5763.20 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales6305.705763.20 9 OPM %30.1123.59 -PBDT1922.801566.60 23 PBT1613.601272.50 27 NP1114.20995.80 12Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
